Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Zymeworks (ZYME) has a market cap of $0.76 billion USD. According to our data, Zymeworks is ranked No.5421 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.76 B |
-24.51%
|
| Dec 31, 2024 | $1.01 B |
40.90%
|
| Dec 29, 2023 | $0.72 B |
32.19%
|
| Dec 30, 2022 | $0.54 B |
-52.04%
|
| Dec 31, 2021 | $1.13 B |
-65.32%
|
| Dec 31, 2020 | $3.26 B |
3.96%
|
| Dec 31, 2019 | $3.13 B |
209.67%
|
| Dec 31, 2018 | $1.01 B |
93.34%
|
| Dec 29, 2017 | $0.52 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 Exelixis
EXEL
|
$10.23 B |
0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
USA
|
 MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Genmab
GMAB
|
$11.92 B |
22.767 M
|
Denmark
|
 BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
China
|
 Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
UK
|
 Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
USA
|
| Market Cap | = | ZYME Stock Price | * | ZYME Shares Outstanding |
| = | $10.94 | * | 69.58 M | |
| = | $0.76 B |